Advances in Diagnosis and Treatment of Hypertrophic Cardiomyopathy
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 2652
Special Issue Editor
Interests: heart failure; cardiomyopathies; valvular heart disease; cardiac imaging; echocardiography; MRI; computed tomography; invasive imaging; diagnosis; therapy; risk stratification; prognosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is my great pleasure to be Guest Editor of the Special Issue dealing with the topic of Diagnosis and Treatment of Hypertrophic Cardiomyopathy (HCM). Despite the significant progress noted in the diagnosis and management of HCM, there is still room for good quality research, for new and sound scientific achievements. The aim of the Special Issue is to gather articles dealing with diagnostic and therapeutic issues related to HCM, sharing new, clinically relevant information about the role and value of diverse imaging or other types of diagnostic modalities and therapeutical methods in the management of the disease. You are cordially invited to send your manuscripts containing your new research results or your review concerning a hot topic in the field of HCM diagnosis and therapy. Also, case reports reflecting important or difficult problems of clinical practice are welcome.
Dr. Attila Frigy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hypertrophic cardiomyopathy
- cardiac imaging
- echocardiography
- MRI
- diagnosis
- pharmacotherapy
- invasive therapy
- risk stratification
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
